quinazolines has been researched along with monoethyl phosphate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beal, AM; Berger, SB; Bertin, J; Bury, MJ; Capriotti, CA; Casillas, LN; Charnley, AK; Convery, MA; Desai, BM; Dong, X; Erhard, KF; Gough, PJ; Haile, PA; Hanning, CR; Kelly, M; Kenna, JK; King, BW; Lipshutz, DB; MacDonald, TT; Mahajan, MK; Marquis, RW; Mehlmann, JF; Nagilla, R; Ouellette, MT; Reilly, MA; Rivera, EJ; Romano, JJ; Schaeffer, MC; Stemp, G; Sun, HH; Vossenkämper, A; Votta, BJ; Wang, GZ | 1 |
1 other study(ies) available for quinazolines and monoethyl phosphate
| Article | Year |
|---|---|
Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[
Topics: Animals; Benzothiazoles; Colitis; Dogs; Drug Discovery; Humans; Male; Mice; Molecular Docking Simulation; Phosphates; Protein Kinase Inhibitors; Quinazolines; Rats, Sprague-Dawley; Receptor-Interacting Protein Serine-Threonine Kinase 2; Swine; Swine, Miniature | 2019 |